NPR-C抗体 [4C3]

IHC-P analysis of breast adenocarcinoma tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of human ovary adenocarcinoma tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

Flow cytometric analysis of Jurkat cells, using anti-NPR3 antibody(GTX84010),(Red) compared to a nonspecific negative control antibody(TA50011)(Blue).

IHC-P analysis of endometrium adenocarcinoma tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

FACS analysis of HEK293T cells transfected with either NPR-C plasmid(Red) or empty vector control plasmid(Blue) using GTX84010 NPR-C antibody [4C3].

IHC-P analysis of thyroid tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

WB analysis of HEK293T cells transfected with NPR-C plasmid (Right) or empty vector (Left) for 48 hrs using GTX84010 NPR-C antibody [4C3].
Loading : 5 ug per lane

IHC-P analysis of colon tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of prostate carcinoma tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of lung tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of pancreas tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

HEK293T cells transfected with either pCMV6-ENTRY NPR3

IHC-P analysis of colon adenocarcinoma tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of kidney tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of prostate tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

IHC-P analysis of bladder tissue using GTX84010 NPR-C antibody [4C3].
Antigen retrieval : Heat-induced epitope retrieval by 10mM citrate buffer, pH6.0, 100ºC for 10min.
Dilution : 1:50

ICC/IF analysis of SVT2 cells using GTX84010 NPR-C antibody [4C3].
Dilution : 1:200

WB analysis of SVT2 cell lysate using GTX84010 NPR-C antibody [4C3].
Loading : 10 ug per lane
Dilution : 1:200

FACS analysis of Jurkat cells using GTX84010 NPR-C antibody [4C3].
Red : Primary antibody
Blue : Negative control antibody